A recently updated systematic review found no benefit from any currently available anticoagulant in acute ischaemic stroke [35]. They included standard unfractionated heparin, low-molecular-weight heparins, heparinoids, oral anticoagulants, and thrombin inhibitors in their analysis.
They are not recommended in the treatment of acute ischaemic stroke at present.